For decades, pancreatic cancer has remained one of the most difficult cancers to treat. Most patients are diagnosed at an ...

When 83-year-old Miami resident Hernando Salcedo noticed his stomach swelling in May 2025, the diagnosis that followed was ...

Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

The 2026 National Comprehensive Cancer Network (NCCN) guidelines now separate HER2– disease further, into HER2 null (no membrane staining at all), HER2 ultra-low (IHC 0 with faint, incomplete membrane ...

July is Sarcoma Awareness Month and according to Cleveland Clinic, sarcoma accounts for about 1 percent of adult cancers but 15 percent to 20 percent of childhood cancers. The Black community speaks ...

Summit Therapeutics has released more Phase III trial data for ivonescimab in non-small cell lung cancer (NSCLC) as it awaits ...

People with DLBCL or high-grade B-cell lymphoma may be hospitalized after receiving their first full dose of EPKINLY on Day 15 of Cycle 1 due to the risk of CRS and neurologic problems. People with FL ...

A new drug is doubling survival time for pancreatic cancer patients. Daraxonrasib, the drug being taken by former Sen. Ben ...

At the Texas Medical Center, research on new drugs and treatments are changing survival rates for some of the most difficult ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...